UBS Maintains Buy on Visteon, Lowers Price Target to $96
UBS analyst Joseph Spak maintains Visteon (NASDAQ:VC) with a Buy and lowers the price target from $107 to $96.
Share
Why It Matters
A big bank analyst still likes Visteon but thinks the stock might be worth less money. When an expert lowers their price target, it means they see some bumps ahead but still believe in the company.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.